About Cardinal Health, Inc.
https://www.cardinalhealth.comCardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical.
CEO
Jason M. Hollar
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-04-23 | Forward | 3:2 |
| 1998-11-02 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 817
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
TD Cowen
Buy
UBS
Buy
B of A Securities
Buy
Jefferies
Buy
Mizuho
Outperform
Evercore ISI Group
Outperform
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:31.46M
Value:$6.72B
VANGUARD GROUP INC
Shares:30.82M
Value:$6.58B
BLACKROCK INC.
Shares:30.81M
Value:$6.58B
Summary
Showing Top 3 of 1,616
About Cardinal Health, Inc.
https://www.cardinalhealth.comCardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $64.01B ▲ | $1.65B ▼ | $450M ▲ | 0.7% ▲ | $1.89 ▲ | $911M ▲ |
| Q4-2025 | $60.16B ▲ | $1.77B ▲ | $239M ▼ | 0.4% ▼ | $1 ▼ | $667M ▼ |
| Q3-2025 | $54.88B ▼ | $1.39B ▲ | $506M ▲ | 0.92% ▲ | $2.11 ▲ | $946M ▲ |
| Q2-2025 | $55.26B ▲ | $1.39B ▲ | $400M ▼ | 0.72% ▼ | $1.65 ▼ | $738M ▼ |
| Q1-2025 | $52.28B | $1.33B | $416M | 0.8% | $1.71 | $755M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $4.59B ▲ | $55.23B ▲ | $57.96B ▲ | $-2.88B ▼ |
| Q4-2025 | $3.87B ▲ | $53.12B ▲ | $55.76B ▲ | $-2.78B ▲ |
| Q3-2025 | $3.33B ▼ | $49.87B ▲ | $51.77B ▲ | $-2.95B ▲ |
| Q2-2025 | $3.81B ▲ | $47B ▲ | $49.92B ▲ | $-2.99B ▲ |
| Q1-2025 | $2.87B | $43.06B | $46.34B | $-3.28B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $454M ▲ | $973M ▼ | $-142M ▲ | $-110M ▼ | $719M ▲ | $865M ▼ |
| Q4-2025 | $243M ▼ | $1.53B ▼ | $-1.64B ▲ | $668M ▲ | $548M ▲ | $1.29B ▼ |
| Q3-2025 | $508M ▲ | $2.92B ▲ | $-2.9B ▼ | $-507M ▼ | $-484M ▼ | $2.79B ▲ |
| Q2-2025 | $401M ▼ | $-400M ▲ | $-976M ▼ | $2.33B ▲ | $943M ▲ | $-499M ▲ |
| Q1-2025 | $417M | $-1.65B | $-88M | $-540M | $-2.27B | $-1.74B |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
 GMPD | $3.12Bn ▲ | $3.15Bn ▲ | $3.16Bn ▲ | $3.20Bn ▲ |
 Other Operating Segment | $1.19Bn ▲ | $1.28Bn ▲ | $1.30Bn ▲ | $1.61Bn ▲ |
 Pharmaceutical Member | $47.99Bn ▲ | $50.85Bn ▲ | $50.43Bn ▼ | $55.37Bn ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q1-2025 | Q4-2025 |
|---|---|---|---|---|
 NonUS | $430.00M ▲ | $400.00M ▼ | $410.00M ▲ | $430.00M ▲ |
 UNITED STATES | $54.86Bn ▲ | $54.50Bn ▼ | $51.89Bn ▼ | $59.75Bn ▲ |
CEO
Jason M. Hollar
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-04-23 | Forward | 3:2 |
| 1998-11-02 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 817
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
TD Cowen
Buy
UBS
Buy
B of A Securities
Buy
Jefferies
Buy
Mizuho
Outperform
Evercore ISI Group
Outperform
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:31.46M
Value:$6.72B
VANGUARD GROUP INC
Shares:30.82M
Value:$6.58B
BLACKROCK INC.
Shares:30.81M
Value:$6.58B
Summary
Showing Top 3 of 1,616